REG - AIM - AIM Notice - 11/06/2024

Celadon PharmaceuticalsAnnouncement

11/06/2024 09:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240611:nRSK8513Ra&default-theme=true

RNS Number : 8513R  AIM  11 June 2024

NOTICE

 

11/06/2024 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 AGRONOMICS LIMITED
 1,791  ORDINARY SHARES OF 0.0001P EACH FULLY PAID  (B6QH1J2)(IM00B6QH1J21)

 

 ANGLE PLC
 58,500,000  ORDINARY SHARES OF 10P EACH, FULLY PAID  (3433067)(GB0034330679)

 

 CELADON PHARMACEUTICALS PLC
 238,095  ORDINARY SHARES OF 1P EACH FULLY PAID  (BDQYGP3)(GB00BDQYGP38)

 

 IDOX PLC
 157,232  ORDINARY SHARES OF 1P EACH, FULLY PAID  (0299819)(GB0002998192)

 

 INSIG AI PLC
 6,500,000  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BYV3135)(GB00BYV31355)

 

 KEYSTONE LAW GROUP PLC
 111,564  ORDINARY SHARES OF 0.2P EACH FULLY PAID  (BZ02055)(GB00BZ020557)

 

 NEXT 15 GROUP PLC
 801,538  ORDINARY SHARES OF 2.5P EACH, FULLY PAID  (3002605)(GB0030026057)

 

 PCI-PAL PLC
 75,000  ORDINARY SHARES OF 1P EACH, FULLY PAID  (0973715)(GB0009737155)

 

 POWERHOUSE ENERGY GROUP PLC
 31,240,606  ORDINARY SHARES OF 0.5P EACH FULLY PAID  (B4WQVY4)(GB00B4WQVY43)

 

 RTC GROUP PLC
 19,982  ORDINARY SHARES OF 1P EACH, FULLY PAID  (0292012)(GB0002920121)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUGDLIGBDGSG